Governing
Bioprospecting
Bioprospecting,
since it inherently exists as a multi-national practice, must require some type
of governance to regulate its existence. After the term was coined in 1989, and
then took off as a legitimate form of conservation promotion, it became readily
apparent that there would have to be an international governance agency or set
of standards around the practice. The Convention on Biological Diversity
occurred in 1992 and established standards for the conservation of biological
diversity, the sustainable use of its components and the fair and equitable
sharing of the benefits arising out of the utilization of genetic resources'
(Scholz 195). The Convention promoted new, sustainable ways that
developing countries could capitalize on their biological diversity without
falling into colonialist relationships with the research organizations.
The
CBD gave a voice to the Southern countries, as they posited the power and
importance of their biological diversity. As stated in Article 19 of the
Convention, "Each Contracting Party shall take legislative, administrative or
policy measures, as appropriate, to provide for the effective participation in
biotechnological research activities by those Contracting Parties, especially
developing countries, which provide the genetic resources for such research,
and where feasible in such Contracting Parties" (CBD website). The Convention
gave Southern countries more sovereignty over their natural resources; for any
institution to acquire biological materials, they must have a permit and
negotiate with the host country to establish equitable bonds.
However,
these are the ideal situations, when the CBD is operating at its best, and with
the participating institutions enforcing its regulations. When this is not the
case, activists have deemed it "biopiracy". For more information on the
articles and exact protocol of the CBD, visit its website: http://www.biodiv.org/default.shtml
Why Study These Cases?
The theoretical approach to
bioprospecting is rather vague without looking at individual case
studies. The following three studies seek to be examples of three main
methods and models for bioprospecting, biopiracy, and a middle ground
between the two. When reading through the case studies, and pursuing
the links for each organization, it is important to keep in mind the
differences and similarities between the cases.
Consider the types of governance
involved: is it in the public domain, or run by private interests? Who
are the parties involved: is it mostly corporate interest, or are local
people incorporated into decision making processes? How does the
media function: is discourse contained on the internet, or are there
academic sources about it? Has there been opposition to the projects,
and if so, is it coming from academics or local people? Where is
economic profit going to: local communities or to the corporate
research institute?
Clearly, these are rather dichotomous
relationships, which is why the case study in Tanzania is a good
counterpoint. There is a good middle ground in this example, showing
how even good intentions can become victim to poor decisions,
miscommunications, and complications with commitments. The importance
of knowledge and rights in each case study deeply affect the outcome
and resistance of local people, and these sentiments can affect how
successful a project is. Also, while reading, keep in mind whether or
not the successful model is appropriate on a larger scale, and if it
can be duplicated successfully. If not, is there any applicable way
that bioprospecting can occur equitably?
Finally, if these case studies spark
some interest, please visit the links to more information, and voice
your opinion. Citizen involvement really shapes whether or not these
projects can happen, like in the Chiapas example to follow, the
project only came to an end because of citizen outcry.